CORT vs EIX
Corcept Therapeutics Incorporated (CORT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CORT and EIX stock pages for the full models.
Not investment advice.